- New Malaria Monoclonal Antibodies
Product News: New Malaria Monoclonal AntibodiesMalaria is a mosquito-borne parasitic infection caused by several species of Plasmodium. It is prevalent worldwide in subtropical regions of Africa, Asia and the Americas. Symptoms include fever and headache but can proceed to coma and death.
The majority of deaths are caused by P. falciparum. During the blood stage infection, P. falciparum secretes large quantities of a glycoprotein termed Histidine- Rich Protein II (HRP II). Detection of HRP II in serum or plasma correlates to active parasitemia.
ViroStat has released a new set of monoclonal antibodies to the HRP II protein of P. falciparum. These antibodies should be useful to researchers and those needing to develop rapid tests for this protein. About ViroStat Inc.
ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies, supplying researchers and manufacturers since 1985. Specialties include high affinity antibodies to Flu A, Flu B, RSV & Strep A for use in rapid lateral flow devices as well as antibodies to food-borne pathogens and toxins. Also, many specificities to HCV, HBV, CMV & EBV for use in anti-viral HTS assays